NALOXONE HYDROCHLORIDE
- Product NDC
- 52584-292
- 11-digit product format
- 525840292
- Labeler code
- 52584
- Product ID
- 52584-292_9bc48ebc-55d7-4ded-a78d-a3b861b5261b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- naloxone hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- General Injectables & Vaccines, Inc.
- Application
- ANDA204997
- Marketing category
- ANDA
- Marketing start
- 2019-12-20
- Marketing end
- 2022-05-31
- Substance
- NALOXONE HYDROCHLORIDE
- Active strength
- 0 mg/mL
- Pharmacologic classes
- Opioid Antagonist [EPC],Opioid Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 52584-292-00 | 52584029200 | 1 VIAL, SINGLE-DOSE in 1 BAG (52584-292-00) > 1 mL in 1 VIAL, SINGLE-DOSE | 2019-12-20 | 2022-05-31 | No | No | Current |